Literature DB >> 3280186

Mercury induced antinuclear antibodies in mice: characterization and correlation with renal immune complex deposits.

P Hultman1, S Eneström.   

Abstract

Female SJL and Balb/c mice were given subcutaneous injections of 1.6 mg HgCl2/kg body weight every third day for 2, 4, 8, or 12 weeks. Indirect immunofluorescence using HEp-2 cells as substrate showed that SJL mice developed antinuclear antibodies (ANA) with a predominantly nucleolar and a weaker, homogeneous nuclear pattern after 4 weeks treatment. The nucleolar antigen was sensitive to treatment with trypsin and RNAse, but the antibody was not absorbed by calf liver RNA. The antigen responsible for the homogeneous nuclear pattern was sensitive to treatment with trypsin, DNAse, and acid solution, but reconstitution with histones on acid treated substrate did not restore the fluorescence. The corresponding antibody was not absorbed by double-stranded or single-stranded DNA, and the Crithidia luciliae assay was negative. This suggests that the antigen responsible for the homogeneous ANA pattern is a non-histone chromatin protein. No autoantibodies were found in Balb/c mice. Electron dense immune deposits containing IgG and C3 in a mesangial-vascular pattern developed after 4 weeks mercury treatment in SJL and Balb/c mice. Acid eluate from kidneys of SJL mice with immune deposits contained tissue-bound ANA with a strictly anti-nucleolar pattern, showing that such antibodies make up part of the renal immune deposits. No autoantibodies were found in the eluate from Balb/c mice. The findings demonstrate that mercury induces a polyclonal autoantibody response in SJL mice, and suggests a restricted antibody response with unknown specificity in Balb/c mice, in both cases leading to immune complex deposits in the kidneys.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3280186      PMCID: PMC1541451     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  Quantitative elution studies in experimental immune complex and nephrotoxic nephritis.

Authors:  S R Bartolotti
Journal:  Clin Exp Immunol       Date:  1977-08       Impact factor: 4.330

2.  Identification and characterization of two new soluble nuclear antigens reactive with sera of patients with connective tissue diseases.

Authors:  S Miyawaki; K Kohmoto; N Kurata; T Ofuji
Journal:  Arthritis Rheum       Date:  1978 Sep-Oct

3.  Systemic lupus erythematosus. Morphologic correlations with immunologic and clinical data at the time of biopsy.

Authors:  G S Hill; N Hinglais; F Tron; J F Bach
Journal:  Am J Med       Date:  1978-01       Impact factor: 4.965

4.  Demonstration of antinuclear antibodies in mercuric chloride-induced glomerulopathy in the rat.

Authors:  J J Weening; G J Fleuren; P J Hoedemaeker
Journal:  Lab Invest       Date:  1978-10       Impact factor: 5.662

5.  Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA).

Authors:  G C Sharp; W S Irvin; E M Tan; R G Gould; H R Holman
Journal:  Am J Med       Date:  1972-02       Impact factor: 4.965

6.  Immunohistochemical findings in the renal vascular lesions of progressive systemic sclerosis.

Authors:  M A Gerber
Journal:  Hum Pathol       Date:  1975-05       Impact factor: 3.466

7.  Immunology of DNA. III. Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique.

Authors:  L A Aarden; E R de Groot; T E Feltkamp
Journal:  Ann N Y Acad Sci       Date:  1975-06-30       Impact factor: 5.691

8.  Antibodies to histones in drug-induced and idiopathic lupus erythematosus.

Authors:  M J Fritzler; E M Tan
Journal:  J Clin Invest       Date:  1978-09       Impact factor: 14.808

9.  The kidney in progressive systemic sclerosis: immunohistochemical and antibody elution studies.

Authors:  R C McCoy; C C Tisher; P F Pepe; L A Cleveland
Journal:  Lab Invest       Date:  1976-08       Impact factor: 5.662

10.  The induction of immune complex deposits in mice by peroral and parenteral administration of mercuric chloride: strain dependent susceptibility.

Authors:  P Hultman; S Eneström
Journal:  Clin Exp Immunol       Date:  1987-02       Impact factor: 4.330

View more
  22 in total

1.  Induction of autoimmunity to brain antigens by developmental mercury exposure.

Authors:  Yubin Zhang; Donghong Gao; Valerie J Bolivar; David A Lawrence
Journal:  Toxicol Sci       Date:  2010-11-11       Impact factor: 4.849

2.  Maternal exposure to mercury chloride during pregnancy and lactation affects the immunity and social behavior of offspring.

Authors:  Yubin Zhang; Valerie J Bolivar; David A Lawrence
Journal:  Toxicol Sci       Date:  2013-02-07       Impact factor: 4.849

3.  Interleukin-10 in murine metal-induced systemic autoimmunity.

Authors:  B Häggqvist; P Hultman
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

Review 4.  Mercury: god of Th2 cells?

Authors:  P W Mathieson
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

5.  Analysis of mercury-induced immune activation in nonobese diabetic (NOD) mice.

Authors:  N Brenden; H Rabbani; M Abedi-Valugerdi
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

6.  Anti-fibrillarin autoantibodies in mercury-treated mice.

Authors:  P Hultman; S Eneström; K M Pollard; E M Tan
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

7.  Mercury and silver induce B cell activation and anti-nucleolar autoantibody production in outbred mouse stocks: are environmental factors more important than the susceptibility genes in connection with autoimmunity?

Authors:  M Abedi-Valugerdi
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

8.  Selective induction of anti-fibrillarin autoantibodies by silver nitrate in mice.

Authors:  P Hultman; S Eneström; S J Turley; K M Pollard
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

9.  Effects of decomplementation with cobra venom factor on experimental vasculitis.

Authors:  P W Mathieson; F J Qasim; S Thiru; R G Oldroyd; D B Oliveira
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

10.  Polyclonal human T-cell activation by silicate in vitro.

Authors:  A Ueki; M Yamaguchi; H Ueki; Y Watanabe; G Ohsawa; K Kinugawa; Y Kawakami; F Hyodoh
Journal:  Immunology       Date:  1994-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.